Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BDI's renamed bronchodilators Mini Two-Way Action, Dynafed Asthma Relief on counter.

This article was originally published in The Tan Sheet

Executive Summary

BDI PHARMACEUTICALS RENAMED BRONCHODILATORS MINI TWO-WAY ACTION, DYNAFED Asthma Relief are on-counter now following the Indianapolis-based company's recent decision to drop the previous Mini Thin name for the ephedrine/guaifenesin combination products. The company also recently decided to reformulate the products to increase the amount of guaifenesin from 100 mg per dose to 200 mg, bringing them in line with agency standards for OTC expectorant products.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086796

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel